Overactive and underactive bladder dysfunction is reflected by alterations in urothelial ATP and NO release

被引:60
|
作者
Munoz, Alvaro [1 ]
Smith, Christopher P. [1 ,3 ]
Boone, Timothy B. [1 ,2 ]
Somogyi, George T. [1 ]
机构
[1] Baylor Coll Med, Scott Dept Urol, Lab Neurourol, Houston, TX 77030 USA
[2] Methodist Hosp, Dept Urol, Houston, TX 77030 USA
[3] Michael E Debakey VA Med Ctr, Houston, TX 77030 USA
基金
美国国家卫生研究院;
关键词
Diabetes; Urinary bladder; Urothelium; ATP release; NO release; BOTULINUM-TOXIN-A; SPINAL-CORD-INJURY; NITRIC-OXIDE; URINARY-BLADDER; NERVOUS-SYSTEM; RATS;
D O I
10.1016/j.neuint.2010.12.002
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
ATP and NO are released from the urothelium in the bladder. Detrusor overactivity (DO) following spinal cord injury results in higher ATP and lower NO release from the bladder urothelium. Our aim was to study the relationship between ATP and NO release in (1) early diabetic bladders, an overactive bladder model; and (2) "diuretic" bladders, an underactive bladder model. To induce diabetes mellitus female rats received 65 mg/kg streptozocin (i.v.). To induce chronic diuresis rats were fed with 5% sucrose. At 28 days, in vivo open cystometry was performed. Bladder wash was collected to analyze the amount of ATP and NO released into the bladder lumen. For in vitro analysis of ATP and NO release, a Ussing chamber was utilized and hypoosmotic Krebs was perfused on the urothelial side of the chamber. ATP was analyzed with luminometry or HPLC-fluorometry while NO was measured with a Sievers NO-analyzer. In vivo ATP release was increased in diabetic bladders and unchanged in diuretic bladders. In vitro release from the urothelium followed the same pattern. NO release was unchanged both in vitro and in vivo in overactive bladders whereas it was enhanced in underactive bladders. We found that the ratio of ATP/NO, representing sensory transmission in the bladder, was high in overactive and low in underactive bladder dysfunction. In summary, ATP release has a positive correlation while NO release has a negative correlation with the bladder contraction frequency. The urinary ATP/NO ratio may be a clinically relevant biomarker to characterize the extent of bladder dysfunction. (C) 2010 Elsevier Ltd. All rights reserved.
引用
收藏
页码:295 / 300
页数:6
相关论文
共 50 条
  • [31] Dysfunction of bladder urothelium and bladder urothelial cells in interstitial cystitis
    Graham E.
    Chai T.C.
    Current Urology Reports, 2006, 7 (6) : 440 - 446
  • [32] Correlation Between Cystometric Volumes, ATP Release, and pH in Women With Overactive Bladder Versus Controls EDITORIAL COMMENT
    Cheng, Ying
    Mansfield, Kylie J.
    Allen, Wendy
    Millard, Richard J.
    Burcher, Elizabeth
    Moore, Kate H.
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2013, 68 (12) : 790 - 791
  • [33] ALTERATIONS IN BLADDER UROTHELIAL ACETYLCHOLINE, ATP, PROSTAGLANDIN E2 AND INFLAMMATORY CYTOKINES BY THE CHEMOTHERAPEUTIC AGENT EPIRUBICIN
    Kang, Sung Hyun
    McDermott, Catherine
    Chess-Williams, Russ
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 : 132 - 132
  • [34] UROTHELIAL DYSFUNCTION AND CHRONIC INFLAMMATION IN THE PATIENTS WITH BLADDER OUTLET OBSTRUCTION AND DIFFERENT BLADDER DYSFUNCTION
    Wang, C.
    Lee, C.
    Kuo, H.
    NEUROUROLOGY AND URODYNAMICS, 2014, 33 (06) : 797 - 798
  • [35] A systematic review of neurocognitive dysfunction with overactive bladder medications
    Duong, Vi
    Iwamoto, Aya
    Pennycuff, Jon
    Kudish, Bela
    Iglesia, Cheryl
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2021, 32 (10) : 2693 - 2702
  • [36] Re: Is Coexistent Overactive-Underactive Bladder (with or Without Detrusor Overactivity and Underactivity) a Real Clinical Syndrome?
    Badlani, Gopal
    EUROPEAN UROLOGY, 2020, 78 (02) : 287 - 288
  • [37] Pathophysiology of Urinary Incontinence, Voiding Dysfunction, and Overactive Bladder
    Rahn, David D.
    Roshanravan, Shayzreen M.
    OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA, 2009, 36 (03) : 463 - +
  • [38] A systematic review of neurocognitive dysfunction with overactive bladder medications
    Vi Duong
    Aya Iwamoto
    Jon Pennycuff
    Bela Kudish
    Cheryl Iglesia
    International Urogynecology Journal, 2021, 32 : 2693 - 2702
  • [39] Summary of Anticholinergic Pharmacotherapy Available for Overactive Bladder Dysfunction
    Altaf Mangera
    Christopher R. Chapple
    Current Bladder Dysfunction Reports, 2012, 7 (1) : 51 - 58
  • [40] Summary of Anticholinergic Pharmacotherapy Available for Overactive Bladder Dysfunction
    Mangera, Altaf
    Chapple, Christopher R.
    CURRENT BLADDER DYSFUNCTION REPORTS, 2012, 7 (01) : 51 - 58